Lilly Declares Third-Quarter 2015 Dividend

INDIANAPOLIS, June 15, 2015 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2015 of $0.50 per share on outstanding common stock.

The dividend is payable September 10, 2015, to shareholders of record at the close of business on August 14, 2015.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to: Lauren Zierke; [email protected]; (317) 277-6524

Eli Lilly and Company logo.

 

Logo- http://photos.prnewswire.com/prnh/20031219/LLYLOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lilly-declares-third-quarter-2015-dividend-300099358.html

SOURCE Eli Lilly and Company

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

AZ sold Atacand and Atacand Plus rights in about 70 countries to Cheplapharm.